 | • レポートコード：QFJ1-3974 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、手根管症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、統合的心理療法、その他）、用途別市場規模（病院、専門クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・手根管症候群治療の市場動向 ・企業の競争状況、市場シェア ・手根管症候群治療の種類別市場規模と予測2016-2027（投薬、統合的心理療法、その他） ・手根管症候群治療の用途別市場規模と予測2016-2027（病院、専門クリニック、在宅医療、その他） ・手根管症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・手根管症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・手根管症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・手根管症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・手根管症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc、ALLERGAN、Pfizer Inc、Johnson & Johnson Services、Novartis AG、Teva Pharmaceutical Industries Ltd、Bristol-Myers Squibb Company、Wockhardt Ltd、Mylan N.V、Aurobindo Pharma、Eisai Co., Ltd、Endo Pharmaceuticals Inc） ・結論 |
Carpal Tunnel Syndrome is a medical condition of numbness, weakness, and tingling in the hand due to compression of the median nerve in the wrist. The median nerve is located on the palm side and also known as the carpal tunnel. This nerve is responsible for sensation in the thumb, the index finger, the middle finger, and part of the ring finger. The key work of the median nerve is to supply the impulse to the thumb muscle. Excess pressure in the wrist and the median nerve causes swelling. Some other frequent conditions associated with carpal tunnel syndrome are thyroid dysfunction, high blood pressure, diabetes, and autoimmune disorders such as rheumatoid arthritis. The most common signs and symptoms of carpal tunnel syndrome are tingling, numbness, pain in the thumb, pain and burning that travels up to the arm, weakness in the muscles of the hand, and the wrist pain at night that interferes with sleep. Health care specialists recommend nerve conduction studies, physical examination, and other tests to confirm the presence of carpal tunnel syndrome.
Market Analysis and Insights: Global Carpal Tunnel Syndrome Treatment Market
The global Carpal Tunnel Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carpal Tunnel Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carpal Tunnel Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carpal Tunnel Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carpal Tunnel Syndrome Treatment market.
Global Carpal Tunnel Syndrome Treatment Scope and Market Size
Carpal Tunnel Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carpal Tunnel Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Treatment
Medication
Integrative Therapy
Others
By Route of Administration
Oral
Parenteral
By Drug
Ibuprofen
Prednisone
Triamcinolone
Others
Segment by Application
Hospitals
Specialty Clinics
Homecare
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline plc
ALLERGAN
Pfizer Inc
Johnson & Johnson Services
Novartis AG
Teva Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company
Wockhardt Ltd
Mylan N.V
Aurobindo Pharma
Eisai Co., Ltd
Endo Pharmaceuticals Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carpal Tunnel Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Integrative Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Carpal Tunnel Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Carpal Tunnel Syndrome Treatment Market Perspective (2016-2027)
2.2 Carpal Tunnel Syndrome Treatment Growth Trends by Regions
2.2.1 Carpal Tunnel Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carpal Tunnel Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Carpal Tunnel Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Carpal Tunnel Syndrome Treatment Industry Dynamic
2.3.1 Carpal Tunnel Syndrome Treatment Market Trends
2.3.2 Carpal Tunnel Syndrome Treatment Market Drivers
2.3.3 Carpal Tunnel Syndrome Treatment Market Challenges
2.3.4 Carpal Tunnel Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carpal Tunnel Syndrome Treatment Players by Revenue
3.1.1 Global Top Carpal Tunnel Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Carpal Tunnel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carpal Tunnel Syndrome Treatment Revenue
3.4 Global Carpal Tunnel Syndrome Treatment Market Concentration Ratio
3.4.1 Global Carpal Tunnel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carpal Tunnel Syndrome Treatment Revenue in 2020
3.5 Carpal Tunnel Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Carpal Tunnel Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Carpal Tunnel Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Carpal Tunnel Syndrome Treatment Breakdown Data by Type
4.1 Global Carpal Tunnel Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Carpal Tunnel Syndrome Treatment Forecasted Market Size by Type (2022-2027)
5 Carpal Tunnel Syndrome Treatment Breakdown Data by Application
5.1 Global Carpal Tunnel Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Carpal Tunnel Syndrome Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Carpal Tunnel Syndrome Treatment Market Size (2016-2027)
6.2 North America Carpal Tunnel Syndrome Treatment Market Size by Type
6.2.1 North America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Carpal Tunnel Syndrome Treatment Market Size by Application
6.3.1 North America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Carpal Tunnel Syndrome Treatment Market Size by Country
6.4.1 North America Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Carpal Tunnel Syndrome Treatment Market Size (2016-2027)
7.2 Europe Carpal Tunnel Syndrome Treatment Market Size by Type
7.2.1 Europe Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Carpal Tunnel Syndrome Treatment Market Size by Application
7.3.1 Europe Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Carpal Tunnel Syndrome Treatment Market Size by Country
7.4.1 Europe Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Carpal Tunnel Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Carpal Tunnel Syndrome Treatment Market Size by Type
9.2.1 Latin America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Carpal Tunnel Syndrome Treatment Market Size by Application
9.3.1 Latin America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Carpal Tunnel Syndrome Treatment Market Size by Country
9.4.1 Latin America Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Details
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Carpal Tunnel Syndrome Treatment Introduction
11.1.4 GlaxoSmithKline plc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 ALLERGAN
11.2.1 ALLERGAN Company Details
11.2.2 ALLERGAN Business Overview
11.2.3 ALLERGAN Carpal Tunnel Syndrome Treatment Introduction
11.2.4 ALLERGAN Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.2.5 ALLERGAN Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Details
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Carpal Tunnel Syndrome Treatment Introduction
11.3.4 Pfizer Inc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.3.5 Pfizer Inc Recent Development
11.4 Johnson & Johnson Services
11.4.1 Johnson & Johnson Services Company Details
11.4.2 Johnson & Johnson Services Business Overview
11.4.3 Johnson & Johnson Services Carpal Tunnel Syndrome Treatment Introduction
11.4.4 Johnson & Johnson Services Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Services Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Carpal Tunnel Syndrome Treatment Introduction
11.5.4 Novartis AG Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Teva Pharmaceutical Industries Ltd
11.6.1 Teva Pharmaceutical Industries Ltd Company Details
11.6.2 Teva Pharmaceutical Industries Ltd Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd Carpal Tunnel Syndrome Treatment Introduction
11.6.4 Teva Pharmaceutical Industries Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Ltd Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Carpal Tunnel Syndrome Treatment Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Wockhardt Ltd
11.8.1 Wockhardt Ltd Company Details
11.8.2 Wockhardt Ltd Business Overview
11.8.3 Wockhardt Ltd Carpal Tunnel Syndrome Treatment Introduction
11.8.4 Wockhardt Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.8.5 Wockhardt Ltd Recent Development
11.9 Mylan N.V
11.9.1 Mylan N.V Company Details
11.9.2 Mylan N.V Business Overview
11.9.3 Mylan N.V Carpal Tunnel Syndrome Treatment Introduction
11.9.4 Mylan N.V Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.9.5 Mylan N.V Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Carpal Tunnel Syndrome Treatment Introduction
11.10.4 Aurobindo Pharma Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Eisai Co., Ltd
11.11.1 Eisai Co., Ltd Company Details
11.11.2 Eisai Co., Ltd Business Overview
11.11.3 Eisai Co., Ltd Carpal Tunnel Syndrome Treatment Introduction
11.11.4 Eisai Co., Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.11.5 Eisai Co., Ltd Recent Development
11.12 Endo Pharmaceuticals Inc
11.12.1 Endo Pharmaceuticals Inc Company Details
11.12.2 Endo Pharmaceuticals Inc Business Overview
11.12.3 Endo Pharmaceuticals Inc Carpal Tunnel Syndrome Treatment Introduction
11.12.4 Endo Pharmaceuticals Inc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021)
11.12.5 Endo Pharmaceuticals Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Carpal Tunnel Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Integrative Therapy
Table 4. Key Players of Others
Table 5. Global Carpal Tunnel Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Carpal Tunnel Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Carpal Tunnel Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Carpal Tunnel Syndrome Treatment Market Share by Regions (2016-2021)
Table 9. Global Carpal Tunnel Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Carpal Tunnel Syndrome Treatment Market Share by Regions (2022-2027)
Table 11. Carpal Tunnel Syndrome Treatment Market Trends
Table 12. Carpal Tunnel Syndrome Treatment Market Drivers
Table 13. Carpal Tunnel Syndrome Treatment Market Challenges
Table 14. Carpal Tunnel Syndrome Treatment Market Restraints
Table 15. Global Carpal Tunnel Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Carpal Tunnel Syndrome Treatment Market Share by Players (2016-2021)
Table 17. Global Top Carpal Tunnel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carpal Tunnel Syndrome Treatment as of 2020)
Table 18. Ranking of Global Top Carpal Tunnel Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Carpal Tunnel Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Carpal Tunnel Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Carpal Tunnel Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Carpal Tunnel Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Carpal Tunnel Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Carpal Tunnel Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline plc Company Details
Table 63. GlaxoSmithKline plc Business Overview
Table 64. GlaxoSmithKline plc Carpal Tunnel Syndrome Treatment Product
Table 65. GlaxoSmithKline plc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline plc Recent Development
Table 67. ALLERGAN Company Details
Table 68. ALLERGAN Business Overview
Table 69. ALLERGAN Carpal Tunnel Syndrome Treatment Product
Table 70. ALLERGAN Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 71. ALLERGAN Recent Development
Table 72. Pfizer Inc Company Details
Table 73. Pfizer Inc Business Overview
Table 74. Pfizer Inc Carpal Tunnel Syndrome Treatment Product
Table 75. Pfizer Inc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Inc Recent Development
Table 77. Johnson & Johnson Services Company Details
Table 78. Johnson & Johnson Services Business Overview
Table 79. Johnson & Johnson Services Carpal Tunnel Syndrome Treatment Product
Table 80. Johnson & Johnson Services Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Services Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Carpal Tunnel Syndrome Treatment Product
Table 85. Novartis AG Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Teva Pharmaceutical Industries Ltd Company Details
Table 88. Teva Pharmaceutical Industries Ltd Business Overview
Table 89. Teva Pharmaceutical Industries Ltd Carpal Tunnel Syndrome Treatment Product
Table 90. Teva Pharmaceutical Industries Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Ltd Recent Development
Table 92. Bristol-Myers Squibb Company Company Details
Table 93. Bristol-Myers Squibb Company Business Overview
Table 94. Bristol-Myers Squibb Company Carpal Tunnel Syndrome Treatment Product
Table 95. Bristol-Myers Squibb Company Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Company Recent Development
Table 97. Wockhardt Ltd Company Details
Table 98. Wockhardt Ltd Business Overview
Table 99. Wockhardt Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 100. Wockhardt Ltd Recent Development
Table 101. Mylan N.V Company Details
Table 102. Mylan N.V Business Overview
Table 103. Mylan N.V Carpal Tunnel Syndrome Treatment Product
Table 104. Mylan N.V Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 105. Mylan N.V Recent Development
Table 106. Aurobindo Pharma Company Details
Table 107. Aurobindo Pharma Business Overview
Table 108. Aurobindo Pharma Carpal Tunnel Syndrome Treatment Product
Table 109. Aurobindo Pharma Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 110. Aurobindo Pharma Recent Development
Table 111. Eisai Co., Ltd Company Details
Table 112. Eisai Co., Ltd Business Overview
Table 113. Eisai Co., Ltd Carpal Tunnel Syndrome Treatment Product
Table 114. Eisai Co., Ltd Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 115. Eisai Co., Ltd Recent Development
Table 116. Endo Pharmaceuticals Inc Company Details
Table 117. Endo Pharmaceuticals Inc Business Overview
Table 118. Endo Pharmaceuticals Inc Carpal Tunnel Syndrome Treatment Product
Table 119. Endo Pharmaceuticals Inc Revenue in Carpal Tunnel Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 120. Endo Pharmaceuticals Inc Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carpal Tunnel Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Integrative Therapy Features
Figure 4. Others Features
Figure 5. Global Carpal Tunnel Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Homecare Case Studies
Figure 9. Others Case Studies
Figure 10. Carpal Tunnel Syndrome Treatment Report Years Considered
Figure 11. Global Carpal Tunnel Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Carpal Tunnel Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Carpal Tunnel Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Carpal Tunnel Syndrome Treatment Market Share by Regions (2022-2027)
Figure 15. Global Carpal Tunnel Syndrome Treatment Market Share by Players in 2020
Figure 16. Global Top Carpal Tunnel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carpal Tunnel Syndrome Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Carpal Tunnel Syndrome Treatment Revenue in 2020
Figure 18. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Carpal Tunnel Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Carpal Tunnel Syndrome Treatment Market Share by Type (2016-2027)
Figure 22. North America Carpal Tunnel Syndrome Treatment Market Share by Application (2016-2027)
Figure 23. North America Carpal Tunnel Syndrome Treatment Market Share by Country (2016-2027)
Figure 24. United States Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Carpal Tunnel Syndrome Treatment Market Share by Type (2016-2027)
Figure 28. Europe Carpal Tunnel Syndrome Treatment Market Share by Application (2016-2027)
Figure 29. Europe Carpal Tunnel Syndrome Treatment Market Share by Country (2016-2027)
Figure 30. Germany Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Carpal Tunnel Syndrome Treatment Market Share by Region (2016-2027)
Figure 40. China Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Carpal Tunnel Syndrome Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Carpal Tunnel Syndrome Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Carpal Tunnel Syndrome Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Carpal Tunnel Syndrome Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Carpal Tunnel Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 60. ALLERGAN Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 61. Pfizer Inc Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Services Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 66. Wockhardt Ltd Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 67. Mylan N.V Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 68. Aurobindo Pharma Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 69. Eisai Co., Ltd Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 70. Endo Pharmaceuticals Inc Revenue Growth Rate in Carpal Tunnel Syndrome Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のQT延長症候群治療市場規模・現状・予測（2021年-2027年） Long QT syndrome is a condition which affects repolarization of the heart after a heartbeat. This results in an increased risk of an irregular heartbeat which can result in palpitations, fainting, drowning, or sudden death. These episodes can be triggered by exercise or stress. Other associated symp…- 世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
- 世界のトンネル照明市場規模・現状・予測（2021年-2027年） Tunnel lighting is one kind of lightings that can improve the road conditions in the tunnel, improve the visual enjoyment in the tunnel, reduce driver fatigue, and help improve the tunnel capacity to ensure traffic safety. Market Analysis and Insights: Global Tunnel Lighting Market The global Tunnel…
- 世界のダンディーウォーカー症候群治療市場規模・現状・予測（2021年-2027年） Dandy-Walker Syndrome is a congenital brain malformation of the fluid-filled spaces around the cerebellum. Dandy-Walker Syndrome involves the partial or complete absence of the area of the brain between the two cerebellar hemispheres, and a cyst formation near the lowest part of the skull. An increa…
- 世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…